What's hot
View all perspectives
What's Hot
RheumNow Rheumatology Roundup: Drs. Kavanaugh and Cush
Rheumatology Roundup! Drs. Cush and Kavanaugh convene for their annual impromptu review of some of the best and more interesting abstracts presented at ACR 2021.
Watch video →
TNF Inhibitor Panel Discussion: ACR21 Annual Meeting
RheumNow TNFi faculty convened to discuss several TNFi-related abstracts presented at ACR 21. Panelists: Drs. Aurelie Najm, Janet Pope, David Liew, Eric Dein and Swetha Alexander.
Watch video →
Spondyloarthritis Panel Discussion: ACR21 Meeting
Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood. Abstracts discussed include #0562, #1919, #0907, #0364 and #0919
Watch video →
Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay
Dr. Kay discusses abstract 1940 and abstract 980 presented at the ACR21 annual meeting.
Watch video →
Diagnosing (Bad) VEXAS: The Experts Speak Drs. Beck and Ferrada
Dr. Cush discusses Dr. Marcela Ferrada and Dr. David Beck to discuss VEXAS syndrome and abstract 1426, which was presented at the ACR21 annual meeting.
Watch video →
Pediatric Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses abstracts #1424 presented at the ACR21 annual meeting.
Watch video →
Urine Proteome Advances: What Do They Mean? Dr. Michelle Petri
Dr. Petri reviews abstracts #1422 and #1936, presented at the ACR21 annual meeting.
Watch video →
ACR21 Day 3 Recap: Polypharmacy, New Lupus Drugs, VEXAS, Safety Data
Blurb: Drs. Jack Cush and the RheumNow Faculty Drs. Akhil Sood, Antoni Chan, Olga Petryna and Eric Dein, discuss highlights from Day 3 (Monday) at the ACR21 annual meeting. Abstracts include #1367, #1044, #1444, #1083 and more.
Watch video →
Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles
Dr. Giles discusses abstracts #0831and #0958 presented at the ACR21 annual meeting.
Watch video →
Predictors of TNF Response with Drs. Pope, Dein and Liew
Drs. Janet Pope, David Liew and Eric Dein discuss TNF data presented at the ACR21 annual meeting, including abstracts #1251, #1442, #1448.
Watch video →
Caring for the Older Patient with Rheumatic Disease: Drs. Makris, Yung and Dao
Drs. Kathryn Dao, Una Makris and Raymond Yung discuss the field of geriatric rheumatology and caring for the older patient with rheumatic disease.
Watch video →
Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in infections vs. flares
Drs. Jack Cush, Yuz Yusof, Bella Mehta, Olga Petryna and Rachel Tate review autoinflammatory data presented at the ACR21 annual meeting, including abstracts #1100, #1062, #1426, #0252, #0195, and #1083.
Watch video →
FDA Session Review: Dr. Arthur Kavanaugh
Dr. Kavanaugh discussed the FDA session presented at the ACR21 annual meeting, including safety data and new approvals and indications in several rheumatic diseases, including lupus, ANCA-associated vasculitis, lupus nephritis and more.
Watch video →
The Respiratory Tract and RA with Drs. Sparks, McDermott and Kronzer
Drs. Jeffrey Sparks, Greg McDermott and Vanessa Kronzer discuss work in the area of respiratory disease in RA, mucosal paradigm, RA-ILD, bronchiectasis, as well as their experience as virtual attendees at the ACR21 annual meeting.
Watch video →
Pulmonary Hypertension in Adult Onset Still's Disease: Dr. Jack Cush
Dr. Cush reviews poster #1100 presented at the ACR21 annual meeting.
Watch video →
Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri
Dr. Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the ACR21 annual meeting.
Watch video →
ACR21 Day 2 Recap: CV Risk, Tapering in SpA, Microbiome in PsA, Vit D
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 (Sunday) at the ACR21 Virtual meeting.
Watch video →
Meral K. El Ramahi, MD MeralElRamahiMD
4 years ago
So excited to cover the annual #ACR21 Convergence Conference aside the amazing @Rheumnow Faculty team. A hearty congratulations to our wonderful leader, Dr. Jack Cush @RheumNowNews, for the well-earned designation as an ACR Master. https://t.co/v6fAyqH1CU
David Liew drdavidliew
4 years ago
Congratulations to all the ACR Masters announced in the #ACR21 Opening Session, particularly @RheumNow's Jack Cush.
It's been such a privilege learning from you. Amongst all you've done, thank you for opening up the global rheumatology discussion like never before. True impact! https://t.co/MMh8owLfY6
CreakyJoints will present 11 posters and two oral presentations at ACR 2021. COVID-19 research revealed significantly high levels of anxiety, anger, depression, and social isolation, which were linked to medication interruptions and associated flares suggesting during the pandemic, patients often felt unsupported by all levels of the healthcare system.
The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021. Below is a listing of some of their best studies for you to review and look for in the meeting. Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.
Bristol Myers Squibb
Dr. John Cush RheumNow
4 years ago
Intensive RA Rx in the TITRATE study showed Disease activity & less remission in in obese patients, but Anxiety, depression and health perceptions were associated with higher pain and fatigue scores. These are unaccounted for in Rx strategies https://t.co/B8izEjfz8P
Dr. John Cush RheumNow
4 years ago
How I Treat Rheumatoid Arthritis
My Stepwise Approach to DMARD, Biologic and Targeted Synthetic Use in RA patients
QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21 (November 5-9, 2021)
https://t.co/jizbQ0Bgxq https://t.co/fXLheKv5dw
Dr. John Cush RheumNow
4 years ago
Treat-to-Target Works in Gout With No Cardiac Toxicity
New research presented this week at ACR Convergence shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. #ARC21
Read more...
https://t.co/r2usSxNnfZ https://t.co/GIgAP3T2hd
Dr. John Cush RheumNow
4 years ago
Industry Abstract Previews #ACR21 - Horizon, Aurinia, AstraZeneca Save
The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021.
https://t.co/ePZHXG5iih https://t.co/xxecyJzwkK
Dr. John Cush RheumNow
4 years ago
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow
4 years ago
Negative Concerns of Telemedicine in Rheumatology
Post-pandemic structured surveys and interviews with rheum patients suggests they may prefer for face-to-face consultations, as telehealth visits run the risk of diagnostic inaccuracies & safety concerns.
https://t.co/FBZ2B1U6Ad https://t.co/1tX35jV76I
Dr. John Cush RheumNow
4 years ago
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.
David Liew drdavidliew
4 years ago
Pre-ACR is always a good time for a bit of a breath, so we can actually see the forest for the trees #ACR21 @RheumNow https://t.co/lKQF5GziyP
Dr. John Cush RheumNow
4 years ago
New Download Available!
The Scary Side of Steroid. Log in to RheumNow to download.
https://t.co/0OfMAsFvWu https://t.co/FpT4aqV8pV
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. Importantly, both urate-lowering therapies were very effective with 90% of patients reaching target urate levels. Additionally, both appeared safe, with no evidence of increased cardiovascular toxicity (Abstract #1900).
Podcasts
Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie00:20:18 -
Reproductive Health in Rheumatic Diseases: Drs. Bermas, Buyon and Dao
00:20:26 -
The Expert Gout Panel with Drs. Neogi, Saag, Pillinger, Cush and O'Dell
00:35:26
Poster Hall